Search – Page 3 – Indianapolis Business Journal

Home » Search

People

Ketan Paranjanpe
More Results (2)

Articles

Roche completes buildings as part of $300M overhaul

October 27, 2016

Since 2012, the company has built five buildings, refurbished existing buildings, made upgrades to IT infrastructure, and increased investments in its diabetes care manufacturing technology.

Roche sees more sales success with penny-pinching hospitals

February 23, 2015

The future of U.S. health care will be about precision and parsimony. And Roche Diagnostics Corp. think its new line of DNA-level testing machines are just what the doctor ordered.

Roche drug trial backs Lilly on Alzheimer’s findings

July 28, 2014

Results of a Roche clinical trial mirror those produced by an experimental Lilly drug two years ago. Lilly executives say that validates their approach in the multi-billion-dollar race to market the first drug to reverse Alzheimer’s.

Roche battles payment cuts while growing diagnostics business

April 28, 2014

New tests have helped Roche Diagnostics grow its North American revenue, excluding its troubled diabetes care business, 23 percent over the past five years. But the money for diagnostic tests continues to go down in key areas, noted CFO Wayne Burris.

Roche’s diabetes biz bounces back—for now

April 21, 2014

Roche Diagnostics Corp. saw a stunning 13-percent boost in sales in its North American diabetes care business during the first quarter, although neither company management nor stock analysts expect that trend to last.

Hurdles remain for Roche Diagnostics on HPV test

March 17, 2014

Roche could enjoy a huge increase in sales of its HPV tests if all doctors and women followed a recommendation issued last week by an advisory committee at the FDA. But wrinkles in the U.S. health care system still present several big obstacles.

Falling reimbursements force Roche to innovate

February 6, 2014

U.S. sales are plunging for Roche Diagnostics Corp. and its fellow makers of diabetes-care devices because of lower reimbursements from the federal Medicare program. In five years, two of the four largest companies will have sold or closed their diabetes businesses, according to two industry analysts.

Lilly drug beats Roche’s Avastin in advanced colon cancer

September 30, 2013

Cancer drug Erbitux extended the lives of patients with a form of advanced colon cancer more than seven months longer than those taking Roche Holding AG’s Avastin.

Roche to cut local jobs after diabetes-care sales plunge

August 5, 2013

Roche’s diabetes care unit, which employs more than 900 in Indianapolis, suffered a 14-percent decline in revenue during the first half of 2013. Roche has reportedly put the unit up for sale.

Report: Roche mulls sale of blood-glucose monitor business

May 16, 2013

Roche Diagnostics Corp. is considering a sale of its blood-glucose meter business, a move that would cast uncertainty over the nearly 1,000 people working for its diabetes business in Indianapolis.

Appeals court upholds Marsh’s $18.2M award from Roche

April 1, 2013

The Indiana Court of Appeals upheld an $18.2 million judgment Monday in favor of Marsh Supermarkets LLC on its complaint alleging that Roche breached a contract to sublease space in the Fishers building that houses Marsh’s headquarters.

Roche makes Fortune’s ‘Best Companies’ list

January 18, 2013

Roche Diagnostics Corp. in Indianapolis ranks 89th on the magazine’s latest “Best Companies to Work For” list and was the only Indiana-based company selected.

Roche continues to restructure diabetes unit

October 22, 2012

Roche officials said last week that price competition and lower reimbursement rates are forcing it to make an unspecified number of cuts in its U.S. sales force and at its research and development hubs in Indianapolis and Germany.

Lilly, Roche drugs chosen for Alzheimer’s prevention trial

October 10, 2012

Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms.

Roche’s diagnostics sales increase 5 percent in first half

July 26, 2012

Roche Holding AG racked up nearly $1.4 billion from North American sales of its diagnostic products, the Swiss drug and device firm reported Thursday.

Roche plans $300M expansion, 100 new jobs

June 20, 2012

Roche Diagnostics Corp. plans to spend $300 million on an expansion of its Indianapolis headquarters, creating 100 jobs by 2017, the company said Wednesday.

Cancer tools help Roche with Alzheimer’s drug

May 14, 2012

Treatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs that attack the same protein as Roche’s experimental drug.

Roche scraps hoped-for cholesterol blockbuster

May 8, 2012

A second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor has failed in testing, casting doubt on whether any of the drugs will ever make it to pharmacies. Eli Lilly is developing a similar drug.

Roche’s downsizing to claim about 80 local IT workers

March 29, 2012

Roche Diagnostics Corp. plans to eliminate about 80 information technology jobs at its Indianapolis-area campus over the next two years, the company said Thursday morning.

« Previous 1 2 3 4 5 … 50 Next »

Search Results

987 results for 'roche'

People

Ketan Paranjanpe